Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Inclusion Criteria: * Non-institutionalized patients with a diagnosis of Alzheimer's disease as defined by Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria with symptoms of delusions or hallucinations, which have been present, at least intermittently for one month or longer * Mini Mental State Examination (MMSE) score of 6 to 24 points * Patients capable of self locomotion or locomotion with the aid of an assistive device * Patients with an identified caregiver or proxy For Extension Phase: Eligible patients were males and females who had completed the 10-week Acute Phase in either treatment group; had a Week 10 Total Score of ≥ 6 on the NPI; and were, in the judgment of the investigator, deemed suitable for participation in the long-term trial. Treatment beyond 140 weeks: All subjects who completed the extension phase of CN138-006 in any French Investigational Site may be considered eligible for entry until they are no longer receiving clinical benefit, per the investigator's judgment Exclusion Criteria: * Patients with an Axis I (DSM IV) diagnosis of: * delirium * amnestic disorders * bipolar disorder * schizophrenia or schizoaffective disorder * mood disorder with psychotic features * Patients with reversible causes of dementia * Patients with psychotic symptoms continuously present since prior to the onset of the symptoms of dementia * Patients with psychotic symptoms that are better accounted for by another genera…